Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
24.05
+0.80 (3.44%)
At close: May 18, 2026, 4:00 PM EDT
24.65
+0.60 (2.49%)
Pre-market: May 19, 2026, 4:25 AM EDT

Progyny Revenue

Progyny had revenue of $328.50M in the quarter ending March 31, 2026, with 1.38% growth. This brings the company's revenue in the last twelve months to $1.29B, up 6.59% year-over-year. In the year 2025, Progyny had annual revenue of $1.29B with 10.40% growth.

Revenue (ttm)
$1.29B
Revenue Growth
+6.59%
P/S Ratio
1.46
Revenue / Employee
$1,510,662
Employees
856
Market Cap
1.88B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.29B121.44M10.40%
Dec 31, 20241.17B-121.44M-9.42%
Dec 31, 20231.29B121.44M10.40%
Dec 31, 20221.17B78.62M7.22%
Dec 31, 20211.09B743.74M215.67%
Dec 31, 2020344.86M115.18M50.15%
Dec 31, 2019229.68M124.28M117.92%
Dec 31, 2018105.40M56.82M116.94%
Dec 31, 201748.58M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group449.71B
CVS Health405.62B
The Cigna Group277.89B
Elevance Health200.42B
Centene178.33B
Humana137.20B
Molina Healthcare43.10B
Oscar Health13.30B
Revenue Rankings